HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2

Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary

Literature (2)

Literature for OMIM 613345: HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2

Xenbase Articles:
(

Denotes literature images)

A novel ATP1A2 mutation in a patient with hypokalaemic periodic paralysis and CNS symptoms., Sampedro Castañeda M,Zanoteli E,Scalco RS,Marques Caldas V,Conti Reed U,da Silva AMS,O'Callaghan B,Bugiardini E,Sud R,McCall S,Poulsen H,Männikkö R,Scaramuzzi V,Phadke R,Hanna MG,Matthews E, Brain. December 1, 2018; 141(12):1460-2156.
Evaluation of mutant muscle Ca2+ channel properties using two different expression systems., Allard B, J Gen Physiol. July 2, 2018; 150(7):1540-7748.

A novel ATP1A2 mutation in a patient with hypokalaemic periodic paralysis and CNS symptoms., Sampedro Castañeda M,Zanoteli E,Scalco RS,Marques Caldas V,Conti Reed U,da Silva AMS,O'Callaghan B,Bugiardini E,Sud R,McCall S,Poulsen H,Männikkö R,Scaramuzzi V,Phadke R,Hanna MG,Matthews E, Brain. December 1, 2018; 141(12):1460-2156.

Evaluation of mutant muscle Ca2+ channel properties using two different expression systems., Allard B, J Gen Physiol. July 2, 2018; 150(7):1540-7748.